GSK has announced plans to close its site in Stevenage and move approximately 1,000 staff to a new research and development facility on the Cambridge Biomedical Campus. The company has had a presence in Stevenage for 50 years but says the new location will 'accelerate our R&D and help us deliver new, competitive products.'
GSK to relocate 1,000 staff from Stevenage to Cambridge
UKPulse News DeskPharmaceutical giant GSK is moving its research and development site from Stevenage to Cambridge, with the relocation expected to be completed by 2029.
- GSK will move approximately 1,000 staff to a new research and development facility on the Cambridge Biomedical Campus.
- The company will close its site in Stevenage as part of the relocation.
- GSK will invest £400m in the new site and upgrade its existing R&D laboratories at Ware in Hertfordshire.
Why this matters: The relocation could have significant implications for the life sciences industry in the UK, with GSK citing the 'exceptional opportunities for collaboration' on the Cambridge Biomedical Campus.
What this means for you: If you work in the life sciences industry, the relocation could impact your job or collaborations with GSK.